IDH1 and glioblastoma: We build an ML model using radiomics features to predict mutations of the isocitrate dehydrogenase NADP+ 1 (IDH1) gene, which has been shown to be a marker of oncogenesis and is one of the most specific biomarkers in the diagnostic classification of secondary glioblastoma multiforme [34].